Late-infantile neuronal ceroid lipofuscinosis (CLN2) is characterized by onset between ages 1 and 4 years, presenting with early language delay, seizures, ataxia, rapid cognitive and motor decline, and blindness. This evidence concerns the gene TPP1 and neuronal ceroid lipofuscinosis.